These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7915606)

  • 21. Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant.
    Fedrowitz M; Lindemann S; Löscher W; Gernert M
    Neuroscience; 2003; 118(3):867-78. PubMed ID: 12710993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asphyctic lesion: proliferation of tyrosine hydroxylase-immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission.
    Bjelke B; Andersson K; Ogren SO; Bolme P
    Brain Res; 1991 Mar; 543(1):1-9. PubMed ID: 1675922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
    Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
    Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat.
    Klein RL; Dayton RD; Lin WL; Dickson DW
    Neurobiol Dis; 2005 Oct; 20(1):64-73. PubMed ID: 16137567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.
    Ferrari CC; Pott Godoy MC; Tarelli R; Chertoff M; Depino AM; Pitossi FJ
    Neurobiol Dis; 2006 Oct; 24(1):183-93. PubMed ID: 16901708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats.
    Anichtchik OV; Huotari M; Peitsaro N; Haycock JW; Männistö PT; Panula P
    Eur J Neurosci; 2000 Nov; 12(11):3823-32. PubMed ID: 11069577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
    Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
    Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X; Yang HA; Wang XN; Du YF
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel black-hooded mutant rat (ci3) with spontaneous circling behavior but normal auditory and vestibular functions.
    Lessenich A; Lindemann S; Richter A; Hedrich HJ; Wedekind D; Kaiser A; Löscher W
    Neuroscience; 2001; 107(4):615-28. PubMed ID: 11720785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical studies of mesolimbic dopaminergic neurons in Fischer 344 and Lewis rats.
    Harris HW; Nestler EJ
    Brain Res; 1996 Jan; 706(1):1-12. PubMed ID: 8720486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
    J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroinvasive Nocardia asteroides GUH-2 induces apoptosis in the substantia nigra in vivo and dopaminergic cells in vitro.
    Tam S; Barry DP; Beaman L; Beaman BL
    Exp Neurol; 2002 Oct; 177(2):453-60. PubMed ID: 12429191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of tyrosine hydroxylase and concentrations of monoamines in the substantia nigra and hypothalamus of hereditary microphthalmic rats.
    Shim SH; Kim SJ; Sugahara K; Sugita S; Tanaka H
    Exp Anim; 2001 Oct; 50(5):445-9. PubMed ID: 11769550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local cerebral glucose utilization in the AS/AGU rat: a mutant with movement disorders.
    Lam AG; Campbell JM; Bennett NK; Payne AP; Davies RW; Sutcliffe RG; McCulloch J
    Eur J Neurosci; 1998 Jun; 10(6):1963-7. PubMed ID: 9753083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal infarction in the rat causes a transient reduction of tyrosine hydroxylase immunoreactivity in the ipsilateral substantia nigra.
    Soriano MA; Justicia C; Ferrer I; Rodríguez-Farré E; Planas AM
    Neurobiol Dis; 1997; 4(5):376-85. PubMed ID: 9440126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease.
    Datla KP; Christidou M; Widmer WW; Rooprai HK; Dexter DT
    Neuroreport; 2001 Dec; 12(17):3871-5. PubMed ID: 11726811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.